Supreme Court Scrutinizes FDA's Abortion Pill Approval Amid Safety Debate

March 26, 2024
Supreme Court Scrutinizes FDA's Abortion Pill Approval Amid Safety Debate
  • The US Supreme Court is assessing a case challenging the FDA's approval of the abortion pill Mifepristone.

  • Anti-abortion groups and physicians claim Mifepristone is unsafe for women and girls.

  • The FDA defends its decision with two decades of safety data supporting the drug's use.

  • Supreme Court's considerations include the challengers' standing and the legitimacy of the FDA's approval process.

  • The upcoming decision in June could impact both abortion rights and pharmaceutical regulation in the US.

Summary based on 35 sources


Get a daily email with more World News stories

Sources


Supreme Court to Hear Arguments on Abortion Pill Mifepristone

What Is Mifepristone and How Is It Used?

The New York Times • Mar 26, 2024

What Is Mifepristone and How Is It Used?


More Stories